Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs Oral Oxytocin for Emotional Processing
NCT05532501Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Sep 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) (4 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Neural responses to emotional scenes and Behavioral responses to emotional scenes. Status: unknown.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05532501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05532501.